|
Evaluation of patients with a clinical diagnosis of the amnesic variant of Alzheimer´s disease phenotype without specific treatment. |
|
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant |
|
NeuroEPO in mild-moderate Alzheimer's disease |
|
NeuroEPO-Ataxia-Adults-Phase III |
|
NeuroEPO in stroke |
|
NeuroEPO in patients with Parkinson disease stage II-III |
|
NeuroEPO in patients with Mild-Moderate Alzheimer's disease |
|
NeuroEPO – Type 2 Spinocerebellar Ataxia Phase I-II |
|
NeuroEPO-Stroke. Phase I-II |
|
NeuroEPO in healthy volunteers. |
